Since Fisetin has been shown to induce apoptosis by downregulating bcl2 in the Huh7 cells (HCC cell line) as well [31], this compound deserves special merit to evaluate its anticancer activity against HCC in vivo. This evidence concerns the gene BCL2 and hepatocellular carcinoma.